FDA Drug Application (077123) for HALOBETASOL PROPIONATE by PERRIGO ISRAEL

Back to FDA Applications sponsored by PERRIGO ISRAEL

Application Number077123
Product Number001
FormCREAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameHALOBETASOL PROPIONATE
Active IngredientHALOBETASOL PROPIONATE



Back to FDA Applications sponsored by PERRIGO ISRAEL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.